"#",Jurisdiction,Kind,Display Key,Lens ID,Publication Date,Publication Year,Application Number,Application Date,Priority Numbers,Earliest Priority Date,Title,Abstract,Applicants,Inventors,Owners,URL,Document Type,Has Full Text,Cites Patent Count,Cited by Patent Count,Simple Family Size,Extended Family Size,Sequence Count,CPC Classifications,IPCR Classifications,US Classifications,NPL Citation Count,NPL Resolved Citation Count,NPL Resolved Lens ID(s),NPL Resolved External ID(s),NPL Citations,Legal Status
1,GB,B,GB 2401781 B,140-214-506-336-151,2007-03-28,2007,GB 0311858 A,2003-05-23,GB 0311858 A,2003-05-23,Key handy,,CLARKE MICHELLE JEAN,CLARKE MICHELLE JEAN,,https://lens.org/140-214-506-336-151,Granted Patent,no,13,0,3,3,0,A47G29/10;;A47G29/10,A47G29/10,A4G G1            G1,0,0,,,,EXPIRED
2,GB,A,GB 2401781 A,064-531-023-666-660,2004-11-24,2004,GB 0311858 A,2003-05-23,GB 0311858 A,2003-05-23,Window key holder.,"A key holder 1 comprises a housing 6 which may be attached to, or be integral with, a window frame. The key holder may be retained ion place by a magnetic strip or by screwing it to the window frame. The key holder may have a flap or lid. In use, the key holder ensures that the key to a window is close at hand in case of an emergency, such as a fire, when it might be necessary to use the window as an escape route.",CLARKE MICHELLE JEAN,CLARKE MICHELLE JEAN,,https://lens.org/064-531-023-666-660,Patent Application,no,6,0,3,3,0,A47G29/10;;A47G29/10,A47G29/10,A4G G1            G1,0,0,,,,EXPIRED
3,US,S,US D0986747 S,084-365-870-734-315,2023-05-23,2023,US 202029750227 F,2020-09-11,US 202029750227 F,2020-09-11,Medicament container,,CHATTEM INC,MCBRIDE MICHELLE;;REESE EDWARD;;STRUTHERS KENNETH CLARKE,CHATTEM INC (2021-02-23),https://lens.org/084-365-870-734-315,Design Right,no,32,1,2,2,0,,,0901;;D 9726;;D28/82,1,0,,,"2 Pcs 50ml/1.7oz Glass Deodorant Roller Bottle Empty Roll On Bottles Deodorant Containers DIY Rollerball Bottles For Sunscreen Moisturizer Cosmetics by ConStore Online, published date N/A. Retrieved on Sep. 15, 2022 from URL: https://www.amazon.com/Deodorant-Containers-Rollerball-Sunscreen-Moisturizer/dp/B09798D6GL/r.",ACTIVE
4,WO,A1,WO 2021/113924 A1,139-387-837-347-736,2021-06-17,2021,AU 2020/051362 W,2020-12-11,AU 2019/904705 A,2019-12-12,ORGANOID CULTURES,"The present invention provides improved methods and media for culturing stem cells and propagating organoids. In particular, the methods provide improved methods for culturing normal and tumour or cancer stem cells and their propagation into organoids. Specifically provided are suspension methods with particular utility for scalable organoid expansion, biobanking, experimental manipulation, miniaturization and imaging based high-throughput drug screening.",WALTER & ELIZA HALL INST MEDICAL RES,CLARKE JORDAN;;HIROKAWA YUMIKO;;PALMIERI MICHELLE;;SIEBER OLIVER,,https://lens.org/139-387-837-347-736,Patent Application,yes,4,12,5,5,0,C12N5/0062;;C12N2513/00;;C12N5/0693;;C12N2533/90;;C12N2533/90;;C12N5/0693;;C12N5/0068;;C12N2513/00;;C12N2539/00;;C12N2521/00;;C12N2533/52;;C12N2533/54;;C12N2533/70;;C12N2501/11;;C12N2501/115;;C12N2501/13;;C12N2501/135;;C12N2501/15;;C12N2501/415;;C12N2501/42;;C12N2537/10;;C12N5/0693;;C12N2501/727;;C12N2513/00;;C12N2527/00;;C12N2533/90,C12N5/00;;C12N5/09,,5,4,024-658-940-471-788;;155-831-383-857-632;;096-931-089-476-29X;;007-124-120-121-720,10.1016/j.stem.2012.05.009;;22704518;;24277810;;10.1073/pnas.1315710110;;pmc3864329;;25035496;;10.1126/science.1247125;;29692415;;10.1038/s41568-018-0007-6,"NAKANO, T. ET AL.: ""Self-Formation of Optic Cups and Storable Stratified Neural Retina from Human ESCs"", CELL STEM CELL, vol. 10, no. 6, 2012, pages 771 - 785, XP028492663, DOI: 10.1016/j.stem.2012.05.009;;KADOSHIMA, T. ET AL.: ""Self-organization of axial polarity, inside-out layer pattern, and species-specific progenitor dynamics in human ES cell -derived neocortex"", PNAS, vol. 110, no. 50, 10 December 2013 (2013-12-10), pages 20284 - 20289, XP055234150;;LANCASTER, M.A. ET AL.: ""Organogenesis in a dish: Modeling development and disease using organoid technologies"", SCIENCE, vol. 345, no. 6194, 2014, pages 283 - 293, XP055130123, DOI: 10.1126/ science .1247125;;DROST, J. ET AL.: ""Organoids in cancer research"", NATURE REVIEWS, vol. 18, July 2018 (2018-07-01), pages 407 - 418, XP036530545, DOI: 10.1038/s41568-018-0007-6;;See also references of EP 4073232A4",PENDING
5,EP,A1,EP 4073232 A1,110-579-944-595-739,2022-10-19,2022,EP 20900417 A,2020-12-11,AU 2019/904705 A;;AU 2020/051362 W,2019-12-12,ORGANOID CULTURES,,WALTER & ELIZA HALL INST MEDICAL RES,CLARKE JORDAN;;HIROKAWA YUMIKO;;PALMIERI MICHELLE;;SIEBER OLIVER,,https://lens.org/110-579-944-595-739,Patent Application,yes,0,0,5,5,0,C12N5/0062;;C12N2513/00;;C12N5/0693;;C12N2533/90;;C12N2533/90;;C12N5/0693;;C12N5/0068;;C12N2513/00;;C12N2539/00;;C12N2521/00;;C12N2533/52;;C12N2533/54;;C12N2533/70;;C12N2501/11;;C12N2501/115;;C12N2501/13;;C12N2501/135;;C12N2501/15;;C12N2501/415;;C12N2501/42;;C12N2537/10;;C12N5/0693;;C12N2501/727;;C12N2513/00;;C12N2527/00;;C12N2533/90,C12N5/00;;C12N5/09,,0,0,,,,PENDING
6,EP,A4,EP 4073232 A4,115-640-264-953-338,2024-01-24,2024,EP 20900417 A,2020-12-11,AU 2019/904705 A;;AU 2020/051362 W,2019-12-12,ORGANOID CULTURES,,WALTER & ELIZA HALL INST MEDICAL RES,CLARKE JORDAN;;HIROKAWA YUMIKO;;PALMIERI MICHELLE;;SIEBER OLIVER,,https://lens.org/115-640-264-953-338,Search Report,no,4,0,5,5,0,C12N5/0062;;C12N2513/00;;C12N5/0693;;C12N2533/90;;C12N2533/90;;C12N5/0693;;C12N5/0068;;C12N2513/00;;C12N2539/00;;C12N2521/00;;C12N2533/52;;C12N2533/54;;C12N2533/70;;C12N2501/11;;C12N2501/115;;C12N2501/13;;C12N2501/135;;C12N2501/15;;C12N2501/415;;C12N2501/42;;C12N2537/10;;C12N5/0693;;C12N2501/727;;C12N2513/00;;C12N2527/00;;C12N2533/90,C12N5/00;;C12N5/09,,1,0,,,See also references of WO 2021113924A1,PENDING
7,AU,A1,AU 2020/399785 A1,175-921-486-295-526,2022-06-30,2022,AU 2020/399785 A,2020-12-11,AU 2019/904705 A;;AU 2020/051362 W,2019-12-12,Organoid cultures,"The present invention provides improved methods and media for culturing stem cells and propagating organoids. In particular, the methods provide improved methods for culturing normal and tumour or cancer stem cells and their propagation into organoids. Specifically provided are suspension methods with particular utility for scalable organoid expansion, biobanking, experimental manipulation, miniaturization and imaging based high-throughput drug screening.",WALTER & ELIZA HALL INST MEDICAL RES,CLARKE JORDAN;;HIROKAWA YUMIKO;;PALMIERI MICHELLE;;SIEBER OLIVER,,https://lens.org/175-921-486-295-526,Patent Application,no,0,0,5,5,0,C12N5/0062;;C12N2513/00;;C12N5/0693;;C12N2533/90;;C12N2533/90;;C12N5/0693;;C12N5/0068;;C12N2513/00;;C12N2539/00;;C12N2521/00;;C12N2533/52;;C12N2533/54;;C12N2533/70;;C12N2501/11;;C12N2501/115;;C12N2501/13;;C12N2501/135;;C12N2501/15;;C12N2501/415;;C12N2501/42;;C12N2537/10;;C12N5/0693;;C12N2501/727;;C12N2513/00;;C12N2527/00;;C12N2533/90,C12N5/00;;C12N5/09,,0,0,,,,PENDING
8,US,A1,US 2023/0029554 A1,112-432-461-416-376,2023-02-02,2023,US 202017784159 A,2020-12-11,AU 2019/904705 A;;AU 2020/051362 W,2019-12-12,ORGANOID CULTURES,"The present invention provides improved methods and media for culturing stem cells and propagating organoids. In particular, the methods provide improved methods for culturing normal and tumour or cancer stem cells and their propagation into organoids. Specifically provided are suspension methods with particular utility for scalable organoid expansion, biobanking, experimental manipulation, miniaturization and imaging based high-throughput drug screening.",THE WALTER AND ELIZA HALL INSTITUTE OF MEDECAL RES,CLARKE JORDAN;;HIROKAWA YUMIKO;;PALMIERI MICHELLE;;SIEBER OLIVER,,https://lens.org/112-432-461-416-376,Patent Application,yes,0,2,5,5,0,C12N5/0062;;C12N2513/00;;C12N5/0693;;C12N2533/90;;C12N2533/90;;C12N5/0693;;C12N5/0068;;C12N2513/00;;C12N2539/00;;C12N2521/00;;C12N2533/52;;C12N2533/54;;C12N2533/70;;C12N2501/11;;C12N2501/115;;C12N2501/13;;C12N2501/135;;C12N2501/15;;C12N2501/415;;C12N2501/42;;C12N2537/10;;C12N5/0693;;C12N2501/727;;C12N2513/00;;C12N2527/00;;C12N2533/90,C12N5/09,,0,0,,,,PENDING
9,US,A,US 6067481 A,002-856-938-987-645,2000-05-23,2000,US 96814597 A,1997-11-12,US 96814597 A,1997-11-12,Virtual magnetic tape drive library system,"A virtual magnetic tape drive library system that includes a host computer controller, a tape drive subsystem and a virtual multi-tape cartridge unit is set forth. The virtual multi-tape cartridge unit includes a housing having a hollow central cavity, the cavity further includes a central spool with magnetic tape spooled thereon. The central spool supplies magnetic tape to a tape drive subsystem during data processing operations. The magnetic tape has a number of parallel longitudinal data tracks defined thereon, wherein the data tracks are arranged into a number of track groups. Each track group has a logical beginning of media (BOM) field and a logical end of media (EOM) field positioned near respective ends thereof. The logical BOM and EOM fields uniquely identify each track group. Consequently, each data track group emulates a logical sub-tape cartridge that may be individually identified as well as selected for data processing operations thereon.",QUANTUM CORP,SALIBA GEORGE;;HALL MICHELLE M;;CLARKE WESTON ST A,QUANTUM CORPORATION (1997-11-10),https://lens.org/002-856-938-987-645,Granted Patent,yes,6,33,10,10,0,G06F3/0682;;G06F3/0682;;G06F3/0608;;G06F3/0608;;G06F3/061;;G06F3/061;;G06F3/0664;;G06F3/0664;;G11B20/00;;G11B20/00;;G11B20/1202;;G11B20/1202,G06F3/06;;G11B20/00;;G11B20/12,700/214;;360/73.08,1,0,,,"Draft Proposed American National Standard Small Computer System Interface 2 (SCSI II) , Sections 9.1.3 and 9.1.4, American National Standards Institute, Mar. 1990.",EXPIRED
10,EP,B1,EP 0965127 B1,162-635-124-256-993,2006-07-19,2006,EP 98959420 A,1998-11-12,US 9824073 W;;US 96814597 A,1997-11-12,A VIRTUAL MAGNETIC TAPE DRIVE LIBRARY SYSTEM,,QUANTUM CORP,SALIBA GEORGE A;;HALL MICHELLE M;;CLARKE WESTON ST A,QUANTUM CORPORATION (2001-08-22),https://lens.org/162-635-124-256-993,Granted Patent,yes,0,0,10,10,0,G06F3/0682;;G06F3/0682;;G06F3/0608;;G06F3/0608;;G06F3/061;;G06F3/061;;G06F3/0664;;G06F3/0664;;G11B20/00;;G11B20/00;;G11B20/1202;;G11B20/1202,G11B20/12;;G06F3/06;;G11B20/00,,1,0,,,"PATENT ABSTRACTS OF JAPAN vol. 012, no. 129 (P - 692) 21 April 1988 (1988-04-21)",EXPIRED
11,WO,A1,WO 1999/024981 A1,004-653-729-525-80X,1999-05-20,1999,US 9824073 W,1998-11-12,US 96814597 A,1997-11-12,A VIRTUAL MAGNETIC TAPE DRIVE LIBRARY SYSTEM,"A virtual magnetic tape drive library system that includes a host computer controller, a tape drive subsystem and a virtual multi-tape cartridge unit is set forth. The virtual multi-tape cartridge unit includes a housing having a hollow central cavity, the cavity further includes a central spool with magnetic tape spooled thereon. The central spool supplies magnetic tape to a tape drive subsystem during data processing operations. The magnetic tape has a number of parallel longitudinal data tracks (60) defined thereon, wherein the data tracks are arranged into a number of track groups (75). Each track group (75) has a logical beginning of media (BOM) field (80) and a logical end of media (EOM) field (85) positioned near respective ends thereof. The logical BOM and EOM fields (80, 85) uniquely identify each track group. Consequently, each data track group emulates a logical sub-tape cartridge (90) that may be individually identified as well as selected for data processing operations thereon.",QUANTUM CORP,SALIBA GEORGE A;;HALL MICHELLE M;;CLARKE WESTON ST A,,https://lens.org/004-653-729-525-80X,Patent Application,yes,5,0,10,10,0,G06F3/0682;;G06F3/0682;;G06F3/0608;;G06F3/0608;;G06F3/061;;G06F3/061;;G06F3/0664;;G06F3/0664;;G11B20/00;;G11B20/00;;G11B20/1202;;G11B20/1202,G06F3/06;;G11B20/00;;G11B20/12,,0,0,,,,PATENTED
12,JP,A,JP 2009043406 A,152-606-568-239-494,2009-02-26,2009,JP 2008272060 A,2008-10-22,US 96814597 A,1997-11-12,VIRTUAL MAGNETIC TAPE DRIVE LIBRARY SYSTEM,"<P>PROBLEM TO BE SOLVED: To provide a virtual magnetic tape drive library system including a host computer control device, a tape drive subsystem and a virtual multi-tape cartridge unit. <P>SOLUTION: A magnetic tape has a number of parallel longitudinal data tracks (60) defined thereon, wherein the data tracks are arranged into a number of track groups (75). Each track group (75) has a logical beginning of media (BOM) field (80) and a logical end of media (EOM) field (85) positioned near respective ends thereof. The logical BOM and EOM fields (80, 85) uniquely identify each track group. Consequently, each data track group emulates a longitudinal sub-tape cartridge (90) that may be individually identified as well as selected for data processing operations thereon. <P>COPYRIGHT: (C)2009,JPO&INPIT",QUANTUM CORP,SALIBA GEORGE A;;HALL MICHELLE M;;CLARKE WESTON ST A,,https://lens.org/152-606-568-239-494,Patent Application,no,2,1,10,10,0,G06F3/0682;;G06F3/0682;;G06F3/0608;;G06F3/0608;;G06F3/061;;G06F3/061;;G06F3/0664;;G06F3/0664;;G11B20/00;;G11B20/00;;G11B20/1202;;G11B20/1202,G11B20/12;;G06F3/06;;G11B20/00,,0,0,,,,PENDING
13,EP,A1,EP 0965127 A1,094-241-549-156-000,1999-12-22,1999,EP 98959420 A,1998-11-12,US 9824073 W;;US 96814597 A,1997-11-12,A VIRTUAL MAGNETIC TAPE DRIVE LIBRARY SYSTEM,,QUANTUM CORP,SALIBA GEORGE A;;HALL MICHELLE M;;CLARKE WESTON ST A,QUANTUM CORPORATION (2001-08-22),https://lens.org/094-241-549-156-000,Patent Application,yes,0,0,10,10,0,G06F3/0682;;G06F3/0682;;G06F3/0608;;G06F3/0608;;G06F3/061;;G06F3/061;;G06F3/0664;;G06F3/0664;;G11B20/00;;G11B20/00;;G11B20/1202;;G11B20/1202,G06F3/06;;G11B20/00;;G11B20/12,,1,0,,,See references of WO 9924981A1,EXPIRED
14,WO,A9,WO 1999/024981 A9,040-151-082-814-322,1999-08-12,1999,US 9824073 W,1998-11-12,US 96814597 A,1997-11-12,A VIRTUAL MAGNETIC TAPE DRIVE LIBRARY SYSTEM,"A virtual magnetic tape drive library system that includes a host computer controller, a tape drive subsystem and a virtual multi-tape cartridge unit is set forth. The virtual multi-tape cartridge unit includes a housing having a hollow central cavity, the cavity further includes a central spool with magnetic tape spooled thereon. The central spool supplies magnetic tape to a tape drive subsystem during data processing operations. The magnetic tape has a number of parallel longitudinal data tracks (60) defined thereon, wherein the data tracks are arranged into a number of track groups (75). Each track group (75) has a logical beginning of media (BOM) field (80) and a logical end of media (EOM) field (85) positioned near respective ends thereof. The logical BOM and EOM fields (80, 85) uniquely identify each track group. Consequently, each data track group emulates a logical sub-tape cartridge (90) that may be individually identified as well as selected for data processing operations thereon.",QUANTUM CORP,SALIBA GEORGE A;;HALL MICHELLE M;;CLARKE WESTON ST A,,https://lens.org/040-151-082-814-322,Patent Application,no,0,0,10,10,0,G06F3/0682;;G06F3/0682;;G06F3/0608;;G06F3/0608;;G06F3/061;;G06F3/061;;G06F3/0664;;G06F3/0664;;G11B20/00;;G11B20/00;;G11B20/1202;;G11B20/1202,G06F3/06;;G11B20/00;;G11B20/12,,0,0,,,,PATENTED
15,WO,A1,WO 2023/048720 A1,081-832-810-308-366,2023-03-30,2023,US 2021/0051981 W,2021-09-24,US 2021/0051981 W,2021-09-24,HIERARCHICAL MOBILE APPLICATION LAUNCH,"Various arrangements are presented for performing a hierarchical application launch of an application. A requests to register one or more smart home devices can be received in association with a user account. The smart home devices can be mapped to the user account based on receiving the requests. An application that is mapped to the user account may be launched; the application can analyze the one or more smart home devices registered to the user account and a user interface hierarchy. Based on analyzing the one or more smart home devices registered to the user account and the user interface hierarchy, an initial launch interface can be selected and output for presentation.",GOOGLE LLC,BILLIG NOEL;;BEEN RACHEL;;BANSAL SAMEER;;ALVAREZ MICHELLE;;HARRIS CLARKE;;CONOVER CHRISTOPHER,,https://lens.org/081-832-810-308-366,Patent Application,yes,2,0,1,1,0,G06F9/451;;G06F9/445;;G05B15/02;;G05B2219/2642;;H04N7/186,G06F9/445;;G05B15/02;;G06F9/451;;H04L12/28;;H04N7/18,,0,0,,,,PENDING
16,SA,B1,SA 03230529 B1,190-754-624-359-03X,2008-06-21,2008,SA 03230529 A,2003-01-26,US 32362501 P;;US 24592702 A,2001-09-20,مركبات البيرازولون fused pyrazolone الملتحمة التى تثبط اطلاق السيتوكينات cytokines الالتهابية,الملخص: يتعلق الاختراع الحالي بالمركب compound الذي يكون قادرا على أن يمنع الإطلاق خارج الخلايا extracellular release د cytokines الالتهابية، إن المركبات المذكورة، المتضمنة كل الأشكال الإنانتيومرية enantiomeric والأشكال الدايستريومرية diasteriomeric وأملاح salts مقبولة دوائيا من ذلك، لها الصيغة:حيث R يشتمل على ethers أو amines؛ R1 هو:(أ) aryl مستبدل أو غير مستبدل؛ أو (ب) heteroaryl مستبدل أو غير مستبدل؛ وحدات R2a و R2b كل منهما على حدة hydrogen،ethers؛ aminesK carboxylates ،amides، أو يمكن أن تشكل الوحدات units المذكورة رابطة مزدوجة carbonyl ،double bond، أو يمكن أن يؤخذ R2aو R2b معا ليشكلا حلقة ring مستبدلة أو غير مستبدلة تحتوي على ٤ إلى ٨ ذرات atoms، تنتقى الحلقة ring المذكورة من المجموعة المتكونة من:(١) carbocyclic؛ (٢) heterocyclic؛ (٣) aryl؛ (٤) heteroaryl؛ (5) bicyclic؛ و,PROCTER & GAMBLE,CLARKE MICHELLE PHILIP;;SWELLER MATTHEW JOHN LAUFER;;DJUNG JANE FAR JINE;;DE BISWANATH,,https://lens.org/190-754-624-359-03X,Granted Patent,no,0,0,105,144,0,C07D487/04;;C07D491/20;;C07D495/20;;A61P1/04;;A61P11/00;;A61P19/02;;A61P29/00;;A61P31/04;;A61P43/00;;A61P7/00;;A61P9/00;;C07D487/04;;C07D487/04;;C07D491/20;;C07D495/20,A61K31/506;;A61K31/5377;;A61K31/5517;;A61P1/04;;A61P7/00;;A61P9/00;;A61P11/00;;A61P19/02;;A61P29/00;;A61P31/04;;A61P43/00;;C07D487/04;;C07D491/113;;C07D491/20;;C07D495/20,,0,0,,,,EXPIRED
17,DK,D0,DK 595187 D0,000-920-290-556-041,1987-11-13,1987,DK 595187 A,1987-11-13,AU PH501786 A;;AU PH603386 A;;AU PH810086 A;;AU PH910486 A;;AU 1968/087000 W,1986-03-13,MINACTIVIN OG FREMGANGSMAADE TIL FREMSTILLING DERAF,"The present invention relates to the production of a novel human protein, minactivin, by recombinant DNA technology, the characterization of the gene sequence, and the expression and purification of large quantities of biologically active minactivin from a recombinant host. It also relates to the purification of biologically active native minactivin, as well as peptides derived from minactivin and their amino acid sequences.",BIOTECH AUSTRALIA PTY LTD;;UNIV AUSTRALIAN,ANTALIS TONI MARIE;;BARNES MICHAEL THOMAS;;CLARKE MICHELLE ALISON;;DEVINE PETER LEONARD;;GOSS NEIL HOWARD;;LEHRBACH PHILIP RALPH,,https://lens.org/000-920-290-556-041,Patent Application,no,0,0,28,52,0,A61K38/00;;C07K14/8132;;G01N33/86;;G01N2333/811;;G01N2333/9723;;A61P29/00;;A61P35/00;;C12N15/00;;G01N33/86;;G01N2333/9723;;G01N2333/811;;C07K14/8132;;A61K38/00,G01N33/50;;A61K38/00;;A61K39/00;;A61K39/395;;A61P29/00;;A61P35/00;;C07H21/04;;C07K1/20;;C07K14/00;;C07K14/195;;C07K14/41;;C07K14/435;;C07K14/81;;C07K16/00;;C12N1/20;;C12N1/21;;C12N5/10;;C12N9/00;;C12N15/09;;C12P21/02;;C12Q1/68;;C12R1/19;;C12R1/91;;G01N33/53;;G01N33/577;;G01N33/58;;G01N33/86,,0,0,,,,EXPIRED
18,WO,A1,WO 1987/005628 A1,156-891-799-119-888,1987-09-24,1987,AU 1968/087000 W,1987-03-13,AU PH501786 A;;AU PH603386 A;;AU PH810086 A;;AU PH910486 A,1986-03-13,MINACTIVIN PRODUCED BY RECOMBINANT DNA TECHNOLOGY,"The present invention relates to the production of a novel human protein, minactivin, by recombinant DNA technology, the characterization of the gene sequence, and the expression and purification of large quantities of biologically active minactivin from a recombinant host. It also relates to the purification of biologically active native minactivin, as well as peptides derived from minactivin and their amino acid sequences.",BIOTECH AUSTRALIA PTY LTD;;UNIV AUSTRALIAN,ANTALIS TONI MARIE;;BARNES MICHAEL THOMAS;;CLARKE MICHELLE ALISON;;DEVINE PETER LEONARD;;GOSS NEIL HOWARD;;LEHRBACH PHILIP RALPH,,https://lens.org/156-891-799-119-888,Patent Application,yes,1,2,28,52,14,A61K38/00;;C07K14/8132;;G01N33/86;;G01N2333/811;;G01N2333/9723;;A61P29/00;;A61P35/00;;C12N15/00;;G01N33/86;;G01N2333/9723;;G01N2333/811;;C07K14/8132;;A61K38/00,A61K38/00;;A61K39/00;;A61K39/395;;A61P29/00;;A61P35/00;;C07H21/04;;C07K1/20;;C07K14/00;;C07K14/195;;C07K14/41;;C07K14/435;;C07K14/81;;C07K16/00;;C12N1/20;;G01N33/50;;C12N1/21;;C12N5/10;;C12N9/00;;C12N15/09;;C12P21/02;;C12Q1/68;;C12R1/19;;C12R1/91;;G01N33/53;;G01N33/577;;G01N33/58;;G01N33/86,C3H HB7P          HB7P;;C3H H650          HB7P;;C3H H656          HB7P;;C3H H687          HB7P;;U1S S1313;;U1S S1337,6,6,018-477-649-785-749;;077-440-303-989-331;;055-909-202-645-166;;016-649-078-999-457;;000-287-550-770-589;;043-656-471-854-718,10.1016/s0021-9258(18)67369-7;;3090045;;10.1042/bj2300109;;pmc1152593;;2932100;;10.1055/s-0038-1660125;;3879018;;6416839;;10.1111/j.1432-1033.1983.tb07771.x;;pmc2187313;;6374011;;10.1084/jem.159.6.1653;;10.1016/0092-8674(82)90220-3;;6210439,"JOURNAL OF BIOLOGICAL CHEMISTRY, Volume 261, No. 24, August 25, 1986, (Bethesda, Maryland, USA), KRUITHOF, E.K.O. et al., ""Purification and Characterization of a Plasminogen Activator Inhibitor from the Histiocytic Lymphoma Cell Line U-937"", pages 11207-11213.;;BIOCHEMIAL JOURNAL, Volume 230, issued 1985, (Essex, England), CHAPMAN, H.A. Jr. and O.L. STONE, ""Characterization of a Macrophage-Derived Plasminogen-Activator Inhibitor"", pages 109-116.;;THROMBOSIS AND HAEMOSTATIS, Volume 54, No. 4, issued 1985, (Verlag, Stuttgart, West Germany), KOPITAR M. et al., ""Human Leucocyte Urokinase Inhibitor - Purification, Characterization and Comparative Studies Against Different Plasminogen Activators"", pages 750-755.;;EUROPEAN JOURNAL OF BIOCHEMISTRY, Volume 136, No. 3, issued 1983, (Springer-Verlag, Heidelberg, West Germany), GOLDER et al., ""Minactivin: A Human Monocyte Product Which Specifically Inactivates Urokinase-Type Plasminogen Activators"", pages 517-522.;;JOURNAL OF EXPERIMENTAL MEDICINE, Volume 159, issued 1984, (Mit Press, Maryland, USA), VASSALI, J.D. et al., ""Concomitant Secretion of Prourokinase and of a Plasminogen Activator - Specific Inhibitor by Cultured Human Monocytes - Macrophages"", pages 1653-1668.;;CELL, Volume 28, issued 1982, (Rockefeller University Press, New York, USA), CHAPMAN, H. A. et al., ""Macrophage Fibrinolytic Activity: Identification of Two Pathways of Plasmin Formation by Intact Cells and of a Plasminogen Activator Inhibitor"", pages 653-662.",PENDING
19,KR,B1,KR 960001820 B1,066-555-052-941-106,1996-02-05,1996,KR 870701038 A,1987-11-13,AU PH501786 A;;AU PH603386 A;;AU PH810086 A;;AU PH910486 A;;AU 1968/087000 W,1986-03-13,METHOD FOR PRODUCING MINACTIVIN,"The present invention relates to the production of a novel human protein, minactivin, by recombinant DNA technology, the characterization of the gene sequence, and the expression and purification of large quantities of biologically active minactivin from a recombinant host. It also relates to the purification of biologically active native minactivin, as well as peptides derived from minactivin and their amino acid sequences.",BIOTECH AUSTRALIA PTY LTD;;UNIV AUSTRALIAN,ANTALIS TONI MARIE;;BARNES MICHAEL THOMAS;;CLARKE MICHELLE ALISON;;DEVINE PETER LEONARD;;GOSS NEIL HOWARD;;LEHRBACH PHILIP RALPH,,https://lens.org/066-555-052-941-106,Granted Patent,no,0,0,28,52,0,A61K38/00;;C07K14/8132;;G01N33/86;;G01N2333/811;;G01N2333/9723;;A61P29/00;;A61P35/00;;C12N15/00;;G01N33/86;;G01N2333/9723;;G01N2333/811;;C07K14/8132;;A61K38/00,A61K38/00;;A61K39/00;;A61K39/395;;G01N33/50;;A61P29/00;;A61P35/00;;C07H21/04;;C07K1/20;;C07K14/00;;C07K14/195;;C07K14/41;;C07K14/435;;C07K14/81;;C07K16/00;;C12N1/20;;C12N1/21;;C12N5/10;;C12N9/00;;C12N15/09;;C12P21/02;;C12Q1/68;;C12R1/19;;C12R1/91;;G01N33/53;;G01N33/577;;G01N33/58;;G01N33/86,,0,0,,,,EXPIRED
20,NO,L,NO 874704 L,144-597-041-026-44X,1987-11-11,1987,NO 874704 A,1987-11-11,AU PH501786 A;;AU PH603386 A;;AU PH810086 A;;AU PH910486 A;;AU 1968/087000 W,1986-03-13,MINAKTIVIN FREMSTILT VED REKOMBINANT DNA-TEKNIKK.,"The present invention relates to the production of a novel human protein, minactivin, by recombinant DNA technology, the characterization of the gene sequence, and the expression and purification of large quantities of biologically active minactivin from a recombinant host. It also relates to the purification of biologically active native minactivin, as well as peptides derived from minactivin and their amino acid sequences.",BIOTECH AUSTRALIA PTY LTD;;UNIV AUSTRALIAN,ANTALIS TONI MARIE;;BARNES MICHAEL THOMAS;;CLARKE MICHELLE ALISON;;DEVINE PETER LEONARD;;GOSS NEIL HOWARD;;LEHRBACH PHILIP RALPH,,https://lens.org/144-597-041-026-44X,Abstract,no,0,0,28,52,0,A61K38/00;;C07K14/8132;;G01N33/86;;G01N2333/811;;G01N2333/9723;;A61P29/00;;A61P35/00;;C12N15/00;;G01N33/86;;G01N2333/9723;;G01N2333/811;;C07K14/8132;;A61K38/00,A61K38/00;;A61K39/00;;A61K39/395;;G01N33/50;;A61P29/00;;A61P35/00;;C07H21/04;;C07K1/20;;C07K14/00;;C07K14/195;;C07K14/41;;C07K14/435;;C07K14/81;;C07K16/00;;C12N1/20;;C12N1/21;;C12N5/10;;C12N9/00;;C12N15/09;;C12P21/02;;C12Q1/68;;C12R1/19;;C12R1/91;;G01N33/53;;G01N33/577;;G01N33/58;;G01N33/86,,0,0,,,,EXPIRED
21,AU,A,AU 1987/071655 A,165-458-607-612-213,1987-10-09,1987,AU 1987/071655 A,1987-03-13,AU 1987/071655 A;;AU PH501786 A,1986-03-13,MINACTIVIN PRODUCED BY RECOMBINANT DNA TECHNOLOGY,,AUSTRALIAN NATIONAL UNIVERSITY THE;;BIOTECHNOLOGY AUSTRALIA PTY LIMITED,ANTALIS TONI MARIE;;BARNES MICHAEL THOMAS;;CLARKE MICHELLE ALISON;;DEVINE PETER LEONARD;;GOSS NEIL HOWARD;;LEHRBACH PHILIP RALPH,,https://lens.org/165-458-607-612-213,Patent Application,no,0,3,2,52,0,,A61K39/395;;A61K49/00;;C07G99/00;;C07H21/04;;C12N1/20;;C12N1/21;;C12N5/00;;C12N5/10;;C12N15/00;;C12N15/15;;C12P19/34;;C12P21/02;;C12Q1/68;;G01N33/53,,0,0,,,,EXPIRED
22,DK,A,DK 595187 A,174-921-764-681-798,1988-07-21,1988,DK 595187 A,1987-11-13,AU PH501786 A;;AU PH603386 A;;AU PH810086 A;;AU PH910486 A;;AU 1968/087000 W,1986-03-13,MINACTIVIN OG FREMGANGSMAADE TIL FREMSTILLING DERAF,"The invention relates to the preparation of a novel human protein, i.e. minactivin, diamines of recombinant DNA technology, to the characterisation of the gene sequence and to the expression and purification of large quantities of biologically active minactivin from a recombinant host. The invention also relates to the purification of biologically active original minactivin and minactivin-derived peptides and their amino acid sequences.",BIOTECH AUSTRALIA PTY LTD;;UNIV AUSTRALIAN,ANTALIS TONI MARIE;;BARNES MICHAEL THOMAS;;CLARKE MICHELLE ALISON;;DEVINE PETER LEONARD;;GOSS NEIL HOWARD;;LEHRBACH PHILIP RALPH,,https://lens.org/174-921-764-681-798,Patent Application,no,0,0,28,52,0,A61K38/00;;C07K14/8132;;G01N33/86;;G01N2333/811;;G01N2333/9723;;A61P29/00;;A61P35/00;;C12N15/00;;G01N33/86;;G01N2333/9723;;G01N2333/811;;C07K14/8132;;A61K38/00,G01N33/50;;A61K38/00;;A61K39/00;;A61K39/395;;A61P29/00;;A61P35/00;;C07H21/04;;C07K1/20;;C07K14/00;;C07K14/195;;C07K14/41;;C07K14/435;;C07K14/81;;C07K16/00;;C12N1/20;;C12N1/21;;C12N5/10;;C12N9/00;;C12N15/09;;C12P21/02;;C12Q1/68;;C12R1/19;;C12R1/91;;G01N33/53;;G01N33/577;;G01N33/58;;G01N33/86,,0,0,,,,EXPIRED
23,NO,L,NO 952506 L,087-022-173-379-500,1995-06-22,1995,NO 952506 A,1995-06-22,NO 952506 A;;AU PH501786 A;;AU PH603386 A;;AU PH810086 A;;AU PH910486 A;;AU 1968/087000 W;;NO 874704 A,1986-03-13,Antistoffpreparater mot homogent minaktivin og anvendelse derav for påvisning av minaktivin i humane kroppsvæsker,"Antistoffpreparater som er frem- stilt mot homogent minaktivin, inklu- dert homogent rekombinant minaktivin, og fragmenter derav. Anvendelse av an- tistoffene for påvisning av minaktivin i prøver av humane kroppsvæsker.",BIOTECH AUSTRALIA PTY LTD;;UNIV AUSTRALIAN,ANTALIS TONI MARIE;;BARNES THOMAS MICHAEL;;CLARKE MICHELLE ALISON;;DEVINE PETER LEONARD;;GOSS NEIL HOWARD;;LEHRBACH PHILIP RALPH,,https://lens.org/087-022-173-379-500,Abstract,no,0,0,2,52,0,,A61K39/395;;C07K/;;C07K16/18;;C12P21/08,,0,0,,,,DISCONTINUED
24,NO,D0,NO 952506 D0,018-436-445-649-568,1995-06-22,1995,NO 952506 A,1995-06-22,NO 952506 A;;AU PH501786 A;;AU PH603386 A;;AU PH810086 A;;AU PH910486 A;;AU 1968/087000 W;;NO 874704 A,1986-03-13,Antistoffpreparater mot homogent minaktivin og anvendelse derav for påvisning av minaktivin i humane kroppsvæsker,,BIOTECH AUSTRALIA PTY LTD;;UNIV AUSTRALIAN,ANTALIS TONI MARIE;;BARNES THOMAS MICHAEL;;CLARKE MICHELLE ALISON;;DEVINE PETER LEONARD;;GOSS NEIL HOWARD;;LEHRBACH PHILIP RALPH,,https://lens.org/018-436-445-649-568,Patent Application,no,0,0,2,52,0,,A61K39/395;;C07K/;;C07K16/18;;C12P21/08,,0,0,,,,DISCONTINUED
25,AU,B2,AU 608752 B2,057-799-050-331-624,1991-04-18,1991,AU 1987/071655 A,1987-03-13,AU 1987/071655 A;;AU PH501786 A,1986-03-13,MINACTIVIN PRODUCED BY RECOMBINANT DNA TECHNOLOGY,,BIOTECH AUSTRALIA PTY LTD,ANTALIS TONI MARIE;;BARNES MICHAEL THOMAS;;CLARKE MICHELLE ALISON;;DEVINE PETER LEONARD;;GOSS NEIL HOWARD;;LEHRBACH PHILIP RALPH,,https://lens.org/057-799-050-331-624,Granted Patent,no,1,1,2,52,0,,A61K39/395;;A61K49/00;;C07G99/00;;C07H21/04;;C12N1/20;;C12N1/21;;C12N5/00;;C12N5/10;;C12N15/00;;C12N15/15;;C12P19/34;;C12P21/02;;C12Q1/68;;G01N33/53,,0,0,,,,EXPIRED
26,NO,D0,NO 874704 D0,168-204-189-909-768,1987-11-11,1987,NO 874704 A,1987-11-11,AU PH501786 A;;AU PH603386 A;;AU PH810086 A;;AU PH910486 A;;AU 1968/087000 W,1986-03-13,MINAKTIVIN FREMSTILT VED REKOMBINANT DNA-TEKNIKK.,"The present invention relates to the production of a novel human protein, minactivin, by recombinant DNA technology, the characterization of the gene sequence, and the expression and purification of large quantities of biologically active minactivin from a recombinant host. It also relates to the purification of biologically active native minactivin, as well as peptides derived from minactivin and their amino acid sequences.",BIOTECH AUSTRALIA PTY LTD;;UNIV AUSTRALIAN,ANTALIS TONI MARIE;;BARNES MICHAEL THOMAS;;CLARKE MICHELLE ALISON;;DEVINE PETER LEONARD;;GOSS NEIL HOWARD;;LEHRBACH PHILIP RALPH,,https://lens.org/168-204-189-909-768,Patent Application,no,0,0,28,52,0,A61K38/00;;C07K14/8132;;G01N33/86;;G01N2333/811;;G01N2333/9723;;A61P29/00;;A61P35/00;;C12N15/00;;G01N33/86;;G01N2333/9723;;G01N2333/811;;C07K14/8132;;A61K38/00,A61K38/00;;A61K39/00;;A61K39/395;;G01N33/50;;A61P29/00;;A61P35/00;;C07H21/04;;C07K1/20;;C07K14/00;;C07K14/195;;C07K14/41;;C07K14/435;;C07K14/81;;C07K16/00;;C12N1/20;;C12N1/21;;C12N5/10;;C12N9/00;;C12N15/09;;C12P21/02;;C12Q1/68;;C12R1/19;;C12R1/91;;G01N33/53;;G01N33/577;;G01N33/58;;G01N33/86,,0,0,,,,EXPIRED
27,US,A1,US 2016/0206851 A1,011-362-539-071-45X,2016-07-21,2016,US 201614997156 A,2016-01-15,US 201614997156 A;;US 201562104491 P,2015-01-16,MICRO-INFUSION DELIVERY SYSTEM,"An injection catheter system that includes (a) an actuator; (b) an outer needle comprising a sharp tip and a tubular body defining a lumen, and extending distally from the actuator; and (c) an inner needle at least partially disposed within the lumen and extending distally from the actuator, the inner needle having a distal tip configured such that at least a portion of the distal tip has a surface contour with an interstitial cavity adapted to receive a therapeutic gel. The system is configured such that (a) in a first position, the distal tip is fully disposed within the lumen to temporarily retain the therapeutic gel in the interstitial cavity and (b) in a second position, the outer needle is retracted proximally, exposing the interstitial cavity to deliver the therapeutic gel to a target area in a body.",BOSTON SCIENT SCIMED INC,BANNISTER PHILIP;;CLARKE BRENDA;;AOIBHEANN GILL;;HANNON MICHELLE;;NOONE DWAYNE;;FANG FENGNAN;;MOONEY EMMA JANE;;KILCOOLEY JOHN;;PALOMAR-MORENO JAVIER;;FLANAGAN AIDEN;;O'CONNOR TIM,BOSTON SCIENTIFIC SCIMED INC (2016-06-08),https://lens.org/011-362-539-071-45X,Patent Application,yes,5,0,5,5,0,A61M25/0084;;A61M25/0084;;A61B5/287;;A61B5/6855;;A61B17/3468;;A61B17/3468;;A61B17/3478;;A61B17/3478;;A61B18/1492;;A61B18/1492;;A61B2017/00247;;A61B2017/00247;;A61B2017/00685;;A61B2017/00685;;A61B2017/3458;;A61B2017/3458;;A61M25/0136;;A61M25/0152;;A61M25/065;;A61M37/00;;A61M2025/0085;;A61M2025/0085;;A61M2025/0089;;A61M2025/0089;;A61M2025/0175,A61M25/00;;A61B5/00;;A61B5/042;;A61M25/01;;A61M25/06,,0,0,,,,ACTIVE
28,WO,A1,WO 2016/115495 A1,146-414-006-212-229,2016-07-21,2016,US 2016/0013659 W,2016-01-15,US 201562104491 P,2015-01-16,MICRO-INFUSION DELIVERY SYSTEM,"An injection catheter system (100) that includes (a) an actuator (116); (b) an outer needle (120) comprising a sharp tip and a tubular body defining a lumen, and extending distally from the actuator; and (c) an inner needle (112) at least partially disposed within the lumen and extending distally from the actuator, the inner needle having a distal tip (112) configured such that at least a portion of the distal tip has a surface contour with an interstitial cavity adapted to receive a therapeutic gel. The system is configured such that (a) in a first position, the distal tip is fully disposed within the lumen to temporarily retain the therapeutic gel in the interstitial cavity and (b) in a second position, the outer needle is retracted proximally, exposing the interstitial cavity to deliver the therapeutic gel to a target area in a body.",BOSTON SCIENT SCIMED INC,BANNISTER PHILIP;;CLARKE BRENDA;;AOIBHEANN GILL;;HANNON MICHELLE;;NOONE DWAYNE;;FANG FENGNAN;;MOONEY EMMA JANE;;KILCOOLEY JOHN;;PALOMAR-MORENO JAVIER;;FLANAGAN AIDEN;;O'CONNOR TIM,,https://lens.org/146-414-006-212-229,Patent Application,yes,4,0,5,5,0,A61B2017/00247;;A61M2025/0085;;A61M2025/0089;;A61B2017/00685;;A61B17/3468;;A61B17/3478;;A61B18/1492;;A61B2017/3458;;A61M25/0084;;A61B2017/00247;;A61M2025/0085;;A61M2025/0089;;A61B2017/00685;;A61B17/3468;;A61B17/3478;;A61B18/1492;;A61B2017/3458;;A61B5/287;;A61B5/6855;;A61M25/0084;;A61M25/0136;;A61M25/0152;;A61M25/065;;A61M2025/0175;;A61M37/00,A61M25/00,,0,0,,,,PENDING
29,EP,B1,EP 3244957 B1,013-731-348-736-256,2021-09-15,2021,EP 16707252 A,2016-01-15,US 201562104491 P;;US 2016/0013659 W,2015-01-16,MICRO-INFUSION DELIVERY SYSTEM,,BOSTON SCIENT SCIMED INC,BANNISTER PHILIP;;CLARKE BRENDA;;AOIBHEANN GILL;;HANNON MICHELLE;;NOONE DWAYNE;;FANG FENGNAN;;MOONEY EMMA JANE;;KILCOOLEY JOHN;;PALOMAR-MORENO JAVIER;;FLANAGAN AIDEN;;O'CONNOR TIM,,https://lens.org/013-731-348-736-256,Granted Patent,yes,4,0,5,5,0,A61M25/0084;;A61M25/0084;;A61B5/287;;A61B5/6855;;A61B17/3468;;A61B17/3468;;A61B17/3478;;A61B17/3478;;A61B18/1492;;A61B18/1492;;A61B2017/00247;;A61B2017/00247;;A61B2017/00685;;A61B2017/00685;;A61B2017/3458;;A61B2017/3458;;A61M25/0136;;A61M25/0152;;A61M25/065;;A61M37/00;;A61M2025/0085;;A61M2025/0085;;A61M2025/0089;;A61M2025/0089;;A61M2025/0175,A61M25/00;;A61B17/00;;A61B17/34;;A61B18/14,,0,0,,,,ACTIVE
30,US,B2,US 10022519 B2,083-270-016-140-683,2018-07-17,2018,US 201614997156 A,2016-01-15,US 201614997156 A;;US 201562104491 P,2015-01-16,Micro-infusion delivery system,"An injection catheter system that includes (a) an actuator; (b) an outer needle comprising a sharp tip and a tubular body defining a lumen, and extending distally from the actuator; and (c) an inner needle at least partially disposed within the lumen and extending distally from the actuator, the inner needle having a distal tip configured such that at least a portion of the distal tip has a surface contour with an interstitial cavity adapted to receive a therapeutic gel. The system is configured such that (a) in a first position, the distal tip is fully disposed within the lumen to temporarily retain the therapeutic gel in the interstitial cavity and (b) in a second position, the outer needle is retracted proximally, exposing the interstitial cavity to deliver the therapeutic gel to a target area in a body.",BOSTON SCIENT SCIMED INC,BANNISTER PHILIP;;CLARKE BRENDA;;AOIBHEANN GILL;;HANNON MICHELLE;;NOONE DWAYNE;;FANG FENGNAN;;MOONEY EMMA JANE;;KILCOOLEY JOHN;;PALOMAR-MORENO JAVIER;;FLANAGAN AIDEN;;O'CONNOR TIM,BOSTON SCIENTIFIC SCIMED INC (2016-06-08),https://lens.org/083-270-016-140-683,Granted Patent,yes,8,0,5,5,0,A61M25/0084;;A61M25/0084;;A61B5/287;;A61B5/6855;;A61B17/3468;;A61B17/3468;;A61B17/3478;;A61B17/3478;;A61B18/1492;;A61B18/1492;;A61B2017/00247;;A61B2017/00247;;A61B2017/00685;;A61B2017/00685;;A61B2017/3458;;A61B2017/3458;;A61M25/0136;;A61M25/0152;;A61M25/065;;A61M37/00;;A61M2025/0085;;A61M2025/0085;;A61M2025/0089;;A61M2025/0089;;A61M2025/0175,A61M25/00;;A61B5/00;;A61B5/042;;A61B17/00;;A61B17/34;;A61B18/14;;A61M25/01;;A61M25/06;;A61M37/00,,0,0,,,,ACTIVE
31,EP,A1,EP 3244957 A1,067-783-519-145-965,2017-11-22,2017,EP 16707252 A,2016-01-15,US 201562104491 P;;US 2016/0013659 W,2015-01-16,MICRO-INFUSION DELIVERY SYSTEM,,BOSTON SCIENT SCIMED INC,BANNISTER PHILIP;;CLARKE BRENDA;;AOIBHEANN GILL;;HANNON MICHELLE;;NOONE DWAYNE;;FANG FENGNAN;;MOONEY EMMA JANE;;KILCOOLEY JOHN;;PALOMAR-MORENO JAVIER;;FLANAGAN AIDEN;;O'CONNOR TIM,,https://lens.org/067-783-519-145-965,Patent Application,yes,0,0,5,5,0,A61B2017/00247;;A61M2025/0085;;A61M2025/0089;;A61B2017/00685;;A61B17/3468;;A61B17/3478;;A61B18/1492;;A61B2017/3458;;A61M25/0084;;A61B2017/00247;;A61M2025/0085;;A61M2025/0089;;A61B2017/00685;;A61B17/3468;;A61B17/3478;;A61B18/1492;;A61B2017/3458;;A61B5/287;;A61B5/6855;;A61M25/0084;;A61M25/0136;;A61M25/0152;;A61M25/065;;A61M2025/0175;;A61M37/00,A61M25/00,,0,0,,,,ACTIVE
32,US,S,US D0710348 S,126-651-999-063-822,2014-08-05,2014,US 201229432920 F,2012-09-22,US 201229432920 F,2012-09-22,Enclosure for electronic device,,APPLE INC,AKANA JODY;;ANDRE BARTLEY K;;BATAILLOU JEREMY;;COSTER DANIEL J;;DE FOREST LAURA MICHELLE;;DE IULIIS DANIELE;;DEGNER BRETT;;HANKEY M EVANS;;HOENIG JULIAN;;HOWARTH RICHARD P;;IVE JONATHAN P;;KERR DUNCAN ROBERT;;MCBROOM DANIEL L;;NISHIBORI SHIN;;ROHRBACH MATTHEW DEAN;;RUSSELL-CLARKE PETER;;STRINGER CHRISTOPHER J;;WHANG EUGENE ANTONY;;ZÖRKENDÖRFER RICO,APPLE INC (2013-05-07),https://lens.org/126-651-999-063-822,Design Right,no,0,3,1,1,0,,,1402;;D14/300,0,0,,,,ACTIVE
33,US,S,US D0709878 S,014-615-798-244-02X,2014-07-29,2014,US 201229424266 F,2012-06-09,US 201229424266 F,2012-06-09,Display,,AKANA JODY;;ANDRE BARTLEY K;;BATAILLOU JEREMY;;COSTER DANIEL J;;DEFOREST LAURA MICHELLE;;DE IULIIS DANIELE;;GARELLI ADAM TERENCE;;GIDDINGS JOSS;;HAMEL BRADLEY JOSEPH;;HANKEY M EVANS;;HENDREN KEITH;;HOENIG JULIAN;;HOWARTH RICHARD P;;IVE JONATHAN P;;KERR DUNCAN ROBERT;;MATHEW DINESH CHERIAN;;POSNER BRYAN WILLIAM;;ROHRBACH MATTHEW DEAN;;RUSSELL-CLARKE PETER;;SILVANTO MIKAEL;;STRINGER CHRISTOPHER J;;WHANG EUGENE ANTONY;;ZORKENDORFER RICO;;APPLE INC,AKANA JODY;;ANDRE BARTLEY K;;BATAILLOU JEREMY;;COSTER DANIEL J;;DEFOREST LAURA MICHELLE;;DE IULIIS DANIELE;;GARELLI ADAM TERENCE;;GIDDINGS JOSS;;HAMEL BRADLEY JOSEPH;;HANKEY M EVANS;;HENDREN KEITH;;HOENIG JULIAN;;HOWARTH RICHARD P;;IVE JONATHAN P;;KERR DUNCAN ROBERT;;MATHEW DINESH CHERIAN;;POSNER BRYAN WILLIAM;;ROHRBACH MATTHEW DEAN;;RUSSELL-CLARKE PETER;;SILVANTO MIKAEL;;STRINGER CHRISTOPHER J;;WHANG EUGENE ANTONY;;ZORKENDORFER RICO,APPLE INC (2013-01-08),https://lens.org/014-615-798-244-02X,Design Right,no,0,2,2,2,0,,,1402;;D14/371;;D14/374,0,0,,,,ACTIVE
